Pharmena S.A. (WSE:PHR)
3.340
+0.040 (1.21%)
Feb 24, 2026, 5:03 PM CET
Pharmena Market Cap
Pharmena has a market cap or net worth of 36.75 million as of February 24, 2026. Its market cap has decreased by -29.64% in one year.
Market Cap
36.75M
Enterprise Value
36.58M
Revenue
1.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.34
Market Cap Chart
Since August 25, 2008, Pharmena's market cap has decreased from 171.99M to 36.75M, a decrease of -78.63%. That is a compound annual growth rate of -8.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 36.75M | 26.92% |
| Dec 30, 2025 | 28.96M | -32.11% |
| Dec 30, 2024 | 42.66M | -46.06% |
| Dec 29, 2023 | 79.08M | 26.79% |
| Dec 30, 2022 | 62.37M | -29.20% |
| Dec 30, 2021 | 88.10M | -10.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 615.00M |
| Captor Therapeutics Spolka Akcyjna | 455.57M |
| Bioceltix | 407.75M |
| BIOTON | 376.09M |
| Synthaverse | 260.08M |
| Molecure | 159.26M |
| Mabion | 128.33M |
| Poltreg | 123.12M |